Rapamycin protects against rotenone-induced apoptosis through autophagy induction - PubMed (original) (raw)
Rapamycin protects against rotenone-induced apoptosis through autophagy induction
T Pan et al. Neuroscience. 2009.
Abstract
Ubiquitin proteasome system (UPS) and autophagy lysosome pathway (ALP) are the two most important routes for degradation of aggregated/misfolded proteins. Additionally, ALP is so far the only known route to clear entire organelles, such as mitochondria. We proposed that enhancement of ALP may be beneficial for some neurodegenerative disorders, such as Parkinson's disease (PD), in which the accumulation of aggregated/misfolded proteins and the dysfunction of mitochondria are the two major pathogenesis. Mitochondrial complex I inhibitor rotenone, which causes dysfunction mitochondria and UPS, has been considered as one of the neurotoxins related to PD. In this study, rotenone-exposed human neuronal SH-SY5Y cells were used as an in vitro model for us to determine whether autophagy enhancer rapamycin could protect against rotenone-induced injury and its underlying mechanisms. The observed results showed that rapamycin alleviated rotenone-induced apoptosis, whose effects were partially blocked when autophagy related gene 5 (Atg5) was suppressed by Atg5 small interference RNA (siRNA) transfection. Additionally, the results showed that rapamycin pretreatment diminished rotenone-induced accumulation of high molecular weight ubiquitinated bands, and reduced rotenone-induced increase of cytochrome c in cytosolic fraction and decreased mitochondrial marker cytochrome oxidase subunit IV (COX IV) in mitochondrial fraction. The changes in cytochrome c and COX IV indicated that the decreased translocation of cytochrome c from mitochondria to cytosol was probably due to the turn over of entire injured mitochondria. The results that lysosome and mitochondria were colocolized within the cells pretreated with rapamycin and that the mitochondria could be found within autophagy double membrane structures further supported that the damaged mitochondria might be cleared through autophagy, which process has been termed as "mitophagy." Our studies suggested that autophagy enhancer rapamycin is neuroprotective against rotenone-induced apoptosis through autophagy enhancement. We concluded that pharmacologically induction of autophagy by rapamycin may represent a useful therapeutic strategy as disease-modifiers in PD.
Similar articles
- Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.
Moors TE, Hoozemans JJ, Ingrassia A, Beccari T, Parnetti L, Chartier-Harlin MC, van de Berg WD. Moors TE, et al. Mol Neurodegener. 2017 Jan 25;12(1):11. doi: 10.1186/s13024-017-0154-3. Mol Neurodegener. 2017. PMID: 28122627 Free PMC article. Review. - Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement.
Hou L, Xiong N, Liu L, Huang J, Han C, Zhang G, Li J, Xu X, Lin Z, Wang T. Hou L, et al. BMC Neurosci. 2015 Nov 25;16:82. doi: 10.1186/s12868-015-0222-y. BMC Neurosci. 2015. PMID: 26608648 Free PMC article. - Rifampicin inhibits rotenone-induced microglial inflammation via enhancement of autophagy.
Liang Y, Zhou T, Chen Y, Lin D, Jing X, Peng S, Zheng D, Zeng Z, Lei M, Wu X, Huang K, Yang L, Xiao S, Liu J, Tao E. Liang Y, et al. Neurotoxicology. 2017 Dec;63:137-145. doi: 10.1016/j.neuro.2017.09.015. Epub 2017 Oct 3. Neurotoxicology. 2017. PMID: 28986232 - Baicalein Protects against Rotenone-Induced Neurotoxicity through Induction of Autophagy.
Kuang L, Cao X, Lu Z. Kuang L, et al. Biol Pharm Bull. 2017 Sep 1;40(9):1537-1543. doi: 10.1248/bpb.b17-00392. Epub 2017 Jun 28. Biol Pharm Bull. 2017. PMID: 28659545 - Neuroprotective Natural Products for the Treatment of Parkinson's Disease by Targeting the Autophagy-Lysosome Pathway: A Systematic Review.
Wang ZY, Liu JY, Yang CB, Malampati S, Huang YY, Li MX, Li M, Song JX. Wang ZY, et al. Phytother Res. 2017 Aug;31(8):1119-1127. doi: 10.1002/ptr.5834. Epub 2017 May 15. Phytother Res. 2017. PMID: 28504367 Review.
Cited by
- Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection.
Mounsey RB, Teismann P. Mounsey RB, et al. Parkinsons Dis. 2010 Dec 26;2011:617472. doi: 10.4061/2011/617472. Parkinsons Dis. 2010. PMID: 21234411 Free PMC article. - Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.
Moors TE, Hoozemans JJ, Ingrassia A, Beccari T, Parnetti L, Chartier-Harlin MC, van de Berg WD. Moors TE, et al. Mol Neurodegener. 2017 Jan 25;12(1):11. doi: 10.1186/s13024-017-0154-3. Mol Neurodegener. 2017. PMID: 28122627 Free PMC article. Review. - Autophagy is a cell death mechanism in Toxoplasma gondii.
Ghosh D, Walton JL, Roepe PD, Sinai AP. Ghosh D, et al. Cell Microbiol. 2012 Apr;14(4):589-607. doi: 10.1111/j.1462-5822.2011.01745.x. Epub 2012 Feb 8. Cell Microbiol. 2012. PMID: 22212386 Free PMC article. - Lysosomal perturbations in human dopaminergic neurons derived from induced pluripotent stem cells with PARK2 mutation.
Okarmus J, Bogetofte H, Schmidt SI, Ryding M, García-López S, Ryan BJ, Martínez-Serrano A, Hyttel P, Meyer M. Okarmus J, et al. Sci Rep. 2020 Jun 24;10(1):10278. doi: 10.1038/s41598-020-67091-6. Sci Rep. 2020. PMID: 32581291 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources